We first confirmed that high expression of B3GNT3 was positively correlated with resistance to ferroptosis inducers including RSL3, ML162, and ML210, particularly in pancreatic cancer cell lines treated with RSL3 (Fig. 4A, Fig. S4A). This evidence concerns the gene B3GNT3 and pancreatic neoplasm.